Recommendations for the health economics analysis to be performed with a drug to be registered in prevention or treatment of osteoporosis.
W
W
Dere
B
B
Avouac
M
M
Boers
M
M
Buxton
C
C
Christiansen
A
A
Dawson
C
C
Gennari
F
F
Guillemin
H
H
Lawaetz
H
H
Lawetz
F
F
Ornskov
I
I
Roumagnac
J Y
JY
Reginster
D000368:Aged; D003362:Cost-Benefit Analysis; D004358:Drug Therapy / Q000191:economics*; D004335:Drug and Narcotic Control; D017850:Economics, Pharmaceutical; D005260:Female; D017408:Guidelines as Topic; D006801:Humans; D008875:Middle Aged; D017059:Models, Econometric; D015663:Osteoporosis, Postmenopausal / Q000188:drug therapy / Q000191:economics* / Q000517:prevention & control; D017063:Outcome Assessment, Health Care / Q000191:economics*; D011788:Quality of Life